We are driven by Innovation

Who We Are

LGM Pharma is an innovation-driven API and procurement specialist, involved in the distribution of quality cGMP pharma ingredients to leading pharmaceutical companies. We specialize in providing full sourcing options, complete technical capabilities and regulatory support for our products.

A Consultative Approach

Based on the scale and scope of development projects with which we are involved, LGM Pharma is able to provide our customers with a seasoned perspective and valuable insight.

Aggregated Mindshare and Experience

Aggregated Mindshare &
Experience

Aggregated Mindshare & ExperienceWhether it is an ANDA, NDA or a 505(b)2 project, LGM has already supported hundreds of similar projects and has aggregated the mindshare and experience that has been an invaluable resource to our clients.

icon-10

Cost Effective APIs & Large Development Quantities

Cost Effective APIs & Large Development Quantities Based on your specific requirements, we can provide cost effective APIs for initial research and larger development quantities towards product commercialization

#

Fully Accredited & Approved Manufacturing Sites

Fully Accredited & Approved Manufacturing SitesAll of our cGMP APIs originate from fully approved manufacturing sites. LGM Pharma is able to provide technical packages, letters of access (LoA) to filed DMFs and complete assistance towards any regulatory filings.

Our client base consists of a diverse array of pharmaceutical companies,
as well as academic, contract pharma, private-label and
government organizations from around the world, including:

The Vision

API Products

LGM Pharma is a preferred supplier to the biotech and pharmaceutical industry.

Consultative Approach

LGM Pharma provides a seasoned perspective and wealth.

Our Quality Commitment

Our number one priority is providing clients with the highest quality pharmaceutical ingredients

Customer Support

Prompt support and communication on customer issues means faster development times.

We are closely monitoring developments regarding COVID-19 (coronavirus).
Learn more about what we are doing in response to COVID-19 here.

This website uses cookies. By using our site, you agree to our terms of service